CB
CeriBell, Inc.
CBLL · NASDAQ
$23.63 +0.90% (+$0.21)
1M +1.63%
Market Cap $932.3M
P/E Ratio -
Div. Yield -
ROE 44.85%
Piotroski F-Score Weak
2/9Valuation
5 /100
Expensive P/B 7.27x
P/S 9.14x
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 50.90%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 64.73%
Op. margin 68.62%
FCF margin 55.25%
Quality
8 /100
Poor ROE 44.85%
ROA 39.67%
Asset turnover 0.61x
Debt
69 /100
Low Current ratio 9.18x
Int. coverage -35.38x
Debt/Equity 0.17x
Stability
42 /100
Moderate Rev. volatility 20.13%
EPS volatility 121.38%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CBLL
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Xingjuan Chao
Employees
327
Headquarters
Sunnyvale
Evenimente viitoare
03 NOV.
Earnings
Upcoming earnings report